Attenuated type II TGF‐β receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination
Open Access
- 26 February 2004
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 110 (2) , 170-176
- https://doi.org/10.1002/ijc.20111
Abstract
We examined the effect of stable transfection of dominant negative TβR‐II (dn TβR‐II) cDNA in a human oral carcinoma cell line that contained normal Ras and was growth inhibited by TGF‐β1. Two clonal cell lines containing dn TβR‐II were isolated and compared to the vector‐only control and parent cell line. The treatment of cells with exogenous TGF‐β1 resulted in a decrease in ligand‐induced growth inhibition and loss of c‐myc downregulation in test cells compared to controls; transcriptional activation of certain genes including fra‐1 and collagenase was retained. Cells containing dn TβR‐II grew faster in monolayer culture, expressed less keratin 10 and exhibited increased motility and invasion in vitro compared to control cell lines. Endogenous TGF‐β1 production and the regulation of MMP‐2 and MMP‐9 by TGF‐β1 remained unchanged. After orthotopic transplantation to the floor of the mouth in athymic mice, cells containing dn TβR‐II formed comparable numbers of primary tumours at the site of inoculation as controls but the tumours were less differentiated as demonstrated by the absence of keratin 10 immunostaining. Further, metastatic dissemination to the lungs and lymphatics was more evident in grafts of cells containing dn TβR‐II than controls. Taken together, the results demonstrate that attenuation of TGF‐β signalling through transfection of dn TβR‐II cDNA leads to an enhanced growth rate, a loss of tumour cell differentiation and an increase in migration and invasion, characteristics that corresponded to the development of the metastatic phenotype.Keywords
This publication has 29 references indexed in Scilit:
- Autocrine Transforming Growth Factor-β Signaling Mediates Smad-independent Motility in Human Cancer CellsJournal of Biological Chemistry, 2003
- Novel inactivating mutations of transforming growth factor-? type I receptor gene in head-and-neck cancer metastasesInternational Journal of Cancer, 2001
- Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesisOncogene, 2001
- Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFβRIIOncogene, 2000
- Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma developmentOncogene, 1998
- Abnormal cancellous bone collagen metabolism in osteoarthritis.Journal of Clinical Investigation, 1998
- Signaling by the transforming growth factor-β receptorBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1995
- TGF‐β receptor regulation mediates the response to exogenous ligand but is independent of the degree of cellular differentiation in human oral keratinocytesInternational Journal of Cancer, 1994
- Transforming growth factor-β1 acts cooperatively with sodium n-butyrate to induce differentiation of normal human keratinocytesExperimental Cell Research, 1992
- Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor‐βJournal of Cellular Physiology, 1990